Seamless Phase I/II Adaptive Design for Oncology Trials of Molecularly Targeted Agents (Q133806)

From MaRDI portal
Revision as of 16:52, 14 March 2024 by Daniel (talk | contribs) (‎Created claim: MaRDI profile type (P1460): MaRDI publication profile (Q5976449), #quickstatements; #temporary_batch_1710423558064)
scientific article
Language Label Description Also known as
English
Seamless Phase I/II Adaptive Design for Oncology Trials of Molecularly Targeted Agents
scientific article

    Statements

    25
    0 references
    5
    0 references
    903-920
    0 references
    6 June 2014
    0 references
    0 references
    0 references